Principles of Medical Ethics 

Before You Donate

Think very seriously before donating to any breastcancer organization, or fundraising program until you read their Annual Report to see who their top contributors are, and if they have a product that appears frequently in the message the organization sends to the public. That would be unethical and its illegal. The same applies to a request that the public buys products, but does not receive a "donor receipt" for tax-deductible purpose. Read any and all food labels that breastcancer "non-profits" are promoting to raise money. Some organizations tell the public to help them raise money by asking you to visit their websites, but that only gives them "hits" to increase their sponsors.

Another tip, "signing" an online Petition is not acceptable, so don't fall for such antics. An ethical non-profit, or professional will not request your visit to their website, nor use "cookies" placed on your computer when you visit their site.

Purchase the Breastcancer Postage Stamp, the Post Office will always give you your charitable deduction receipt. Its a valid form of fund raising.

 

This is the best  glossary I've come across. To help you, I've put a Miriam Webster Dictionary at the bottom of this page.

This will help you understand what you are hearing about your condition. Initially, just pay attention to the terms that apply to you!

Glossary

Adjuvant chemotherapy/hormone therapy
The use of either chemotherapy or hormone therapy after initial treatment either by surgery or radiotherapy. The aim of adjuvant therapy is to destroy any cancer that has spread. 

Alopecia
Hair loss. It is usually partial, although it can be complete. Full recovery usually occurs fairly quickly. 

Anti-oncogene
See tumor suppressor gene. 

ANZBCTG
Australian and New Zealand Breast Cancer Trials Group. It is a trans-Tasman clinical trials group which conducts research on new treatments for breast cancer. 

Atypia
Abnormal changes in cells. See also dysplasia

Axilla
The armpit. 

Axillary dissection
Surgery to remove fat and lymph nodes from the armpit. It can be done either at the same time as a mastectomy or as a separate operation. It can be partial or complete. 

Benign
Not malignant, not cancer. A benign tumor is not capable of spreading. 

Biopsy
Removal of a sample of tissue or cells from the body to assist in diagnosis of a disease. 

Body image
A person's conception of and feelings about his or her body - its form, size, shape and the way it fits society's norms. Self-esteem and sexuality are linked with body image. 

Bone scan
A test to see whether the cancer has spread to any bones. 

Boost
An extra dose of radiation given to a smaller area, usually the site where the tumor was removed, after the rest of the breast has been irradiated. 

BRCA1
Breast cancer gene 1. A gene which is defective in about 2% of women with breast cancer. See also familial breast cancer

BRCA2
Breast cancer gene 2. Another gene implicated in familial breast cancer. 

Breast conservation
See breast conserving surgery

Breast conserving surgery
Surgery where the cancer is removed, together with a margin of normal breast tissue. The whole breast is not removed. 

Breast reconstruction
The formation of a breast shape after a total mastectomy. 

Breast sharing
A method of reconstruction in which some of the opposite breast is used to reconstruct the missing breast. 

Calcification
The deposition of calcium salts in body tissues. In the breast, it can be associated with either normal or cancerous tissue. 

Carcinoma
A malignant tumor arising from epithelial cells, which are cells lining the external or internal surfaces of the body. Carcinomas spread to nearby tissues. They may also spread to distant sites such as lung, liver, lymph nodes and bone. See also metastasis

Carcinoma in situ
A malignant tumor which has not yet become invasive but is confined to the layer of cells from which it arose. A form of pre-invasive cancer. 

Carcinoma NOS
Invasive ductal carcinoma not otherwise specified. Comprises 70 per cent of all breast cancers. 

Cathepsin D
A protein secreted by breast cancer cells. It may be a marker of poor prognosis. 

Centigray
A measure of radiation. 1 centigray = 1 rad. 

Chemotherapy
The use of medications (drugs) that are toxic to cancer cells. These drugs kills the cells, or prevent or slow their growth. 

Chromosome
A body in the cell nucleus carrying genes. See gene

CLE
See complete local excision

Clinical trial
Research conducted with the patient's permission which usually involves a comparison of two or more treatments or diagnostic methods. The aim is to gain better understanding of the underlying disease process and/or methods to treat it. 

Combined modality treatment
The integration of two or more forms of treatment to combat the cancer. For example: radiation and surgery; radiation and chemotherapy; surgery, radiation and chemotherapy. 

Comedo carcinoma in situ
An aggressive type of breast carcinoma. 

Complete local excision
The complete removal of a tumor with a surrounding margin of normal breast tissue. Also known as CLE and breast conserving surgery. 

Conservative surgery
Surgery in which the breast is not removed. Also known as breast conserving surgery. 

Coping strategies
Strategies or behaviors used to reduce psychological stress. Coping strategies may be influenced by personality style and the specific situation, and may change over time. 

Core biopsy
The sampling of breast tissue with a needle to give a tiny cylinder of tissue for examination by a pathologist. 

Cosmesis
The appearance of the breast following treatment. 

Cribriform
See Non-comedo carcinoma

Cycle
Chemotherapy is usually administered at regular intervals. A cycle is a course of chemotherapy followed by a period in which the body recovers. 

Cytology
An examination by a pathologist of the cellular structure of a tissue. 
DCIS

Ductal carcinoma in situ. A form of breast cancer which requires special consideration. It spreads along the ducts of the breast, rather than forming a lump. 

Denial
Inability to acknowledge something apparent to others. It can be an involuntary coping strategy. 

Depression
A pervasive and sustained lowering of mood. Other features include tearfulness, guilt, irritability, loss of interest in life, loss of energy, poor concentration, poor sleep and loss of appetite. 

Differentiation
The degree to which a tumor resembles normal tissue. In general, the closer the resemblance, the better the prognosis. Well differentiated tumors closely resemble normal tissue. 

Disease-free survival
The time from the primary treatment of the breast cancer to the first evidence of cancer recurrence. 

Ducts
Passages along which milk passes during breastfeeding. 

Ductal carcinoma in situ
See DCIS

Dry desquamation
A reaction to radiotherapy involving the shedding of dry skin. 

Dysplasia 
An abnormal growth of cells which look something like cancer cells, but do not have all the features of cancer. See also atypia

ECOG
Eastern Cooperative Oncology Group. A group of American oncologists which conducts trials on cancer treatments. 

ECOG performance status
A five point scale developed by the Eastern Cooperative Oncology Group.
0 - No symptoms of cancer
1 - Presence of cancer-related symptoms
2 - Spends less than 50% of daylight hours in bed
3 - Spends more than 50%, but less than 100% of daylight hours in bed
4 - Totally confined to bed

EGF-R
Epidermal growth factor receptor. A protein on some cancer cells. Cancers with plenty of EGF-R are likely to be aggressive. See also erbB-2

Electron
The smallest particle of negative electricity. 

EORTC
European Organization for Research and Treatment of Cancer. A group which carries out clinical trials on cancer therapies. 

EORTC core quality of life questionnaire (QLQ)
A questionnaire designed to determine the impact on quality of life of different treatments. 

Epidermal growth factor receptor
See EGF-R

ER
Estrogen receptor. A protein on breast cancer cells that binds estrogens. It indicates that the tumor may respond to hormonal therapies. Tumors with plenty of ER have a better prognosis that those which do not. 

erbB-2
Also known as HER2/neu. A protein similar to EGF-R. Tumors with plenty of erbB-2 are usually aggressive. 

Erythema
Redness of the skin, which is the earliest sign of radiation reaction. 

Familial breast cancer
Breast cancer affecting two or more close relatives, especially in premenopausal women. It implies an inherited disposition. 

Fine needle aspiration biopsy (FNA or FNAB)
See fine needle biopsy. 

Fine needle biopsy (FNB)
The sampling of cells from breast tissue for examination by a pathologist. 

Fraction
Radiotherapy is usually given over several weeks. The dose delivered each day is known as a fraction. 

Free flap reconstruction
Breast reconstruction using microsurgery. 

Frozen section
A rapid method of obtaining a pathological examination of tissue during an operation. This is not routinely used in breast cancer. 

G-CSF
Granulocyte cell stimulating factor. A natural substance which promotes the growth of white cells. It can be used after chemotherapy. 

Gene
The functional unit of heredity. Each gene sits on a chromosome within the cell nucleus. 

Grade
The degree of similarity of the cancer cells to normal cells. This is assessed by a pathologist. A grade 1 carcinoma is well differentiated and is associated with a good prognosis. A grade 2 carcinoma is moderately differentiated and is associated with an intermediate prognosis. A grade 3 carcinoma is poorly differentiated and is associated with a poor prognosis. Grade is assessed by a pathologist.  Note: As of 1997, grade has been given sub-grades to indicate the source of a metastasic for example, or where the malignant cells may have come from to enter the lymphatic system for instance. This is discussed under /biopsyetc.html because the biopsy method may move malignant cells into the blood supply of the woman.

Gray
The modern unit of radiation dosage. Doses used in treatment for early breast cancer range from 45 and 65 Gray. See also rad

Halsted mastectomy
See radical mastectomy

HER2/neu
See erbB-2

Histology
An examination of the structure of a cell by a pathologist. 

Hormone receptors
Proteins in a cell which bind to specific hormones. This binding stimulates the cell to act in a certain way. 

These receptors are present in about 50% of all women with breast cancer. Women with plenty of hormone receptors are likely to respond to hormone treatments, and are more likely to do well than women without hormone receptors. 

Hormone replacement therapy
The use of hormones as a substitute for natural hormones in women. 

Hormone therapy
The use of drugs or hormones which specifically inhibit the growth of hormone responsive cancer cells. 

Hyperplasia
Increased numbers of epithelial cells. If excessive, there is a slightly increased risk of developing subsequent breast carcinoma. 

Immediate reconstruction
The reconstruction of the breast at the time of mastectomy. 

In situ carcinoma
See carcinoma in situ

Increment
See fraction

International Breast Cancer Study Group
An international cooperative group which includes many Australian clinical researchers. The group is carrying out multicentre trials, especially in the area of chemotherapy. 

Iridium (wire)
A radioactive wire often used to deliver the boost to the operative site in breast conserving techniques. 

Large cell in situ carcinoma
See comedo carcinoma

Latissimus dorsi flap
A method of reconstruction using skin from the back, which is carried on the latissimus dorsi muscle. 

LCIS
Lobular carcinoma in situ. It is a misnomer which describes a benign process in the breast. It is not a carcinoma. It is usually detected by chance in the course of a breast biopsy for another lesion. 

Local recurrence
Return of the cancer in the affected breast. 

Limited axillary dissection
Surgery to the armpit in which not all lymph nodes are removed. 

Linear accelerator
Modern radiation equipment capable of delivering x-rays at very high energies. 

Lumpectomy
Surgical removal of a lump from the breast. See complete local excision

Lymphatic system
A system of vessels which drains fluid out of the head, neck and limbs and returns it to the general circulation. 

Lymph node
A small collection of tissue along the lymphatic system which acts as a filter. White cells and cancer cells, in particular, collect in lymph nodes. They are found in the neck, the armpit, the groin and many other places. Lymph nodes are also known as glands. 

Lymphoedema
Swelling in the arm or breast because of a collection of lymphatic fluid. 

Malignant
A tumor having the capacity to destroy tissue locally, spread and cause death. 

Mammogram
A soft tissue x-ray of the breast which may be used to evaluate a lump or which may be used as a screening test in women with no signs or symptoms of breast cancer. 

Mammography
The process of taking a mammogram. 

Margins of resection
The edge of the tissue removed. See complete local excision. 

Mastectomy
Surgical removal of the breast. May be total (all of the breast) or partial. See also radical (Halsted) mastectomy

Medical oncologist
A doctor who specializes in the use of chemotherapy and hormone therapy. 

Megavoltage
High energy X-rays. 

Meta-analysis
A statistical technique used to examine all research on a particular issue. 

Metastasis
The spread of a cancer from the primary site to somewhere else via the bloodstream or the lymphatic system. 

Metastasise
See metastasis

Metastatic cancer
Cancer which has spread to a site distant from the original site. 

Micrometastases
Small undetectable deposits of cancer which grow later. 

Micropapillary
See non-comedo carcinoma

Mitosis
The process of cell division. 

Modified radical mastectomy
Total mastectomy with removal of lymph nodes in the armpit, but without removal of the muscles of the chest. 

Moist desquamation
A response to radiotherapy in which skin peels off. It is made worse by friction and sweat. 

Nadir
The lowest measured value. In cancer treatments, it usually refers to the lowest white blood cell and platelet count. 

Nausea
Feeling sick or wanting to be sick. If it is caused by chemotherapy, it can last for anywhere between a few hours and a week. 

Necrosis
The death of an individual cell or groups of cells in living tissue. Sometimes seen in carcinomas. 

Neutropenia (febrile)
A decreased number of white cells in the blood, which greatly increases the risk of infection. It usually occurs as a result of chemotherapy. 

Nodal status
The presence or absence of cancer in the lymph nodes of the armpit. A woman with cancer in one or more nodes is node positive, or node +ve. A woman with no cancer in her nodes is node negative, or node -ve. 

Non-comedo carcinoma in situ
A low grade type of carcinoma. 

Occult metastasis
A metastasis that has not yet shown up. 

Estrogen receptor
See ER. 

Oncogene
A gene which, functioning abnormally, encourages normal cells to turn cancerous. 

Oncologist
A doctor who specializes in treating cancer. 

Oncology
The study of the biology and physical and chemical features of cancers. Also the study of the cause and treatment of cancers. 

Oncology nurse
A registered nurse who is educated in the care of people with cancer. 

Oophorectomy
Surgery to remove the ovaries. It is sometimes used as a treatment for breast cancer. 

Open biopsy
Surgery performed under local or general anesthetic in which a sample of breast tissue is removed so it can be examined by a pathologist. 

Orthovoltage
X-rays delivered from generators operating at less than 500,000 volts. 

Overall survival
The time from the primary treatment of the breast cancer to death. 

p53
A protein which, when the gene for it is damaged, leads to an increased risk of breast cancer. 

Palliation
The alleviation of symptoms due to the underlying cancer, without prospect of cure. 

Partial mastectomy
Removal of part of the breast. 

Patey's operation
An operation in which the breast and lymph nodes of the armpit are removed, but not the pectoralis major muscle. See also modified radical mastectomy. 

PR
Progesterone receptor. A receptor inside the cell which binds progesterone. Tumors with plenty of PR (PR+) are less aggressive and more responsive to hormone therapy than those without (indicated as PR-).

Predictive factor
Something which helps predict what may happen. For example, the estrogen receptor is a predictive factor for a good response to hormone therapy. 

Premenopausal
Before menopause. 

Postmenopausal
After menopause. 

Primary breast tumor
Tumor arising in the breast. 

Progesterone receptor
See PR

Prognosis
An estimate of what is likely to happen in the future. 

Prognostic factors
Factors which are associated with a better or worse outcome of the disease. They are not the same as causes. 

Progression
The continuing growth of the cancer. 

Prosthesis
An artificial part designed and fitted to overcome a defect in the body. 

Prosthetic breast reconstruction
Creation of a breast shape using an artificial breast. 

Protocol
A detailed program of treatment. 

pS2
A protein which may reflect ER status. People with plenty of pS2 usually have a good prognosis. 

Quadrantectomy
Removal of quarter of the breast. 

Quality of life
The individual's overall appraisal of their situation and subjective sense of well-being. 

Quality of life encompasses symptoms of disease, side- effects of treatment, relationships, how well you get on at work and play and how you cope with daily life. 

QLQ
See EORTC Core Quality of Life Questionnaire (QLQ)

Rad
An old unit of radiation dose now superseded by the Gray. 1 Gray = 100 rads. 

Radiation oncologist
A doctor who specialises in treating cancer with radiation. Also known as a radiotherapist. 

Radical (Halsted) mastectomy
Total mastectomy with removal of all lymph nodes from the armpit and removal of muscles of the chest. This operation is obsolete and should be performed rarely. 

Radiographer
A technician who gives radiotherapy prescribed by a radiation oncologist. 

Radiotherapy
The use of radiation, usually x-rays or gamma rays, to kill tumor cells. 

Rectus flap reconstruction
Breast reconstruction using skin and fat from the abdomen carried on the rectus abdominis muscle, which runs down the middle of your abdomen. Also known as TRAM - transverse rectus abdominis myocutaneous flap. 

Relapse
Recurrence of disease after an initial response to treatment. 

Remission
A reduction or disappearance of the symptoms of cancer. It can be partial or complete. Note: the term 'symptoms' is all that is used for this...there are no objective, clinical analyses to prove the malignancy is gone, as there is with leukemia, etc. Thus this is not a good term to apply to breastcancer
it is many cancers, not one. Web site author

Response to therapy - complete response
The disappearance of all detectable cancer for a minimum of one month. Also known as remission. 

Response to therapy - disease progression
Continued growth of the cancer. 

Response to therapy - partial response (partial remission)
A reduction in size of the cancer of 50% or more. 

Response to therapy - stable disease.
No change in the cancer. 

Scleroderma
A disease involving tightening of the skin and of the lining of the esophagus. 

Secondary reconstruction
Reconstruction of the breast carried out some time after the original mastectomy. 

Secondary tumor
A deposit of breast cancer away from the breast (such as in the lung, bone or lymph node). See metastasis. 

Segmentectomy
The excision of an entire segment of the breast. 

Simulator
A machine which allows a radiation oncologist to calculate the correct dose and position of the radiotherapy. 

Small cell carcinoma
See non-comedo carcinoma

Soft tissue reconstruction
A method of breast reconstruction using the patient's own tissue, transfered from another part of the body. 

Sonographer
A technician trained in performing ultrasounds. 

Specimen X-ray
An X-ray of a surgically removed specimen to confirm that a mammographically detected cancer has been removed. 

Staging
Refers to the allocation of categories (0, I, II, III, IV) to groupings of tumors defined by internationally-agreed criteria. Staging helps determine treatment and prognosis. 

Subcutaneous mastectomy
An operation in which the tissue of the breast is removed but the skin and nipple are not. 

Support group
A group of people you can turn to for emotional support. The group may also provide practical help, information, guidance and feedback about your stressful experiences and ways of coping. 

Surgical oncologist
A surgeon who specialises in the care of people with cancer. 

Telangiectasia
Small dilated blood vessels which appear in areas which have been heavily irradiated. 

Tissue expansion
Creation of a breast shape using an inflatable envelope placed under the skin and muscle. It is gradually expanded over several weeks by repeated injections of salt water. 

Total mastectomy
Surgery to remove the entire breast, including the nipple and areola. 

Toxicity
Side-effects which are due to treatment. 

Transverse rectus abdominis myocutaneous flap (TRAM)
See rectus flap reconstruction

Treatment failure
The inability of the treatment to halt the growth or spread of the cancer. 

Tubular carcinoma
A very well differentiated carcinoma seen increasingly as a result of mammographic screening. 

Tumor
An abnormal growth of tissue. It may be localized (benign) or invade nearby tissues (malignant) or distant tissues (metastatic). 

Tumor suppressor gene
A gene which usually prevents cancers growing. When it is not functioning normally, tumors can grow. Examples include p53 in breast cancer, RB protein in retinoblastoma and possibly BRCA1 in breast cancer. Also known as an anti- oncogene. 

Tumor type
The overall cell pattern of the tumor. 

Ultrasound
The use of sound waves to form a picture of internal tissues. 

Vascular infiltration
Invasion by cancer cells of lymphatics or veins. It is a sign that the tumor is likely to spread. 
 

 
URL:http://www.nbcc.org.au/pages/info/resource/ nbccpubs/clincon/glossary.htm

  Disclaimer: The information provided on the NHMRC National Breast Cancer Centre Home Page is for information only, and is not a substitute for talking to a health professional. The views or opinions stated in external resources which are links on this home page do not necessarily reflect those of the National Breast Cancer Centre.  Website author has given examples in parenthesis for reader's convenience.

 


 

rev. 04/26/06